Take Note! Charting Accuracy Improves Patient Outcomes and Keeps the Lights On – A Guide to Note-Taking for Benign and Malignant Hematologic Disorders (On-Demand)

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 120 Minutes

Overview

This interactive program will describe how to chart, code, and bill properly for benign and malignant hematologic disorders. Expert faculty will identify key pertinent information to formulate a diagnosis for multiple myeloma, lymphoma, and iron deficiency anemia and discuss a care plan. Participants will be guided through each case study, from the patient visits to reimbursement, reviewing proper coding and billing. This program will help improve the learners' note-taking and relationships with multidisciplinary groups and optimize reimbursement.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Develop a history of present illness (HPI) for multiple myeloma, lymphoma, and iron deficiency anemia
  2. Formulate a diagnosis for a hematologic disorder that includes key pertinent information
  3. Devise a care plan specific for each hematologic diagnosis
  4. Discuss the importance of accurate hematologic diagnosis coding, billing, and its impact on reimbursement

 

This Evenings in Onboarding initiative and all content is supported in part by independent medical educational grants from Novocure, Inc., Merck Sharp & Dohme Corp., and Bristol Myers Squibb Company.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.50 credit.
  • 0.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.25 credit.
Course opens: 
11/21/2023
Course expires: 
11/21/2024
Cost:
$0.00
Rating: 
0

Faculty
​​​

Claressa Rosacina, MSN, RN, AGPCNP-BC (Moderator)

Claressa Rosacina is the lead Nurse Practitioner at Oncology Consultants and also serves as their Clinical Support Manager. She leads large teams of APPs and Medical Scribes. She practices closely with the Vice President of the company, Dr. Alex Nguyen. She originally volunteered at MD Anderson Cancer Hospital’s ER and found her calling through working with cancer patients. She then pursued her passion and obtained both her Bachelor and Master of Science in Nursing with a subspecialty in Adult-Gerontology through Texas Woman’s University. 

Claressa first started working at MD Anderson Cancer Hopital as an ICU nurse for five years, then transitioned to Oncology Consultants in 2014 as a Nurse Practitioner. She has served as the lead APP and Clinical Support Manager in 2021, making sure all new APPs and Medical Scribes are well trained in their roles. Her key interests are breast cancer, colon cancer, lymphoma, and leukemia.

She is also passionate about cancer prevention and works very closely with teams in creating a Survivorship Clinic at Oncology Consultants. Claressa is an active member of ONS (Oncology Nursing Society) and a member of Sigma Theta Tau, the International Honor Society of Nursing. Claressa and her husband Raymond Donato share three beautiful children and reside in Houston, TX. She enjoys gardening, dancing, and traveling in her spare time.
 

Sheryl Leahey, NP (Speaker)

Sheryl Leahey earned her Post-Master FNP from Western University of Health Sciences in Pomona, Ca. She currently works at City of Hope National Medical Center specializing in Hematology and Hematopoietic Cell transplants. Sheryl manages patients with multiple myeloma who are treated with chemotherapy, CAR T, Bi-Specific antibodies, autologous transplants, and investigational protocols. Sheryl is an accomplished researcher who has published several papers on multiple myeloma treatments and continues to engage in clinical research and publication.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Sheryl Leahey, NP discloses Advisory Boards with Legend, Biotech Bristol Myers , Pfizer but these relationships have ended, during the past 24 months.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.50 credit.
  • 0.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.25 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above